Home Vitamin D levels, insulin resistance, and cardiovascular risks in very young obese children
Article
Licensed
Unlicensed Requires Authentication

Vitamin D levels, insulin resistance, and cardiovascular risks in very young obese children

  • Ana L. Creo , Joshua S. Rosen , Adolfo J. Ariza , Katherine M. Hidaka and Helen J. Binns EMAIL logo
Published/Copyright: October 25, 2012

Abstract

Objective: To examine the relationships of 25-hydroxyvitamin D (25-OHD) levels with the measures of insulin resistance and cardiovascular risk, and identify the clinical factors associated with low 25-OHD in young obese children.

Design and methods: Data from 83 children ages 2–6 years seen for obesity care (clinic latitude 42°N) were analyzed. Insulin resistance [homeostasis model assessment of insulin resistance (HOMA-IR)] and cardiovascular risks were examined in relationship to 25-OHD levels using correlation statistics. χ2 and logistic regression models were applied to identify the factors associated with vitamin D deficiency (25-OHD levels <20 ng/mL) and insufficiency (<30 ng/mL).

Results: Children’s mean age was mean 4.9 years and they were predominantly Hispanic. Mean body mass index (BMI) Z-score was 3.2 and mean HOMA-IR was 2.8. Mean 25-OHD was 30.9 ng/mL (6% <20 ng/mL and 46% 20–29 ng/mL). There were no significant correlations between 25-OHD and BMI (Spearman’s ρ=–0.096, p=0.389), BMI Z-score (Spearman’s ρ=0.104, p=0.350), HOMA-IR (Spearman’s ρ=–0.144, p=0.269), total cholesterol (Spearman’s ρ=–0.028, p=0.833), or triglycerides (Spearman’s ρ=–0.026, p=0.846). Vitamin D deficiency was significantly associated with older age, lower milk intake, and testing in winter months. 25-OHD level <30 ng/mL was associated with older age, African-American and Hispanic race/ethnicity, and testing in winter months. All factors retained significance in a multivariate logistic regression model, with African-American (odds ratio=14.4) and Hispanic (odds ratio=7.2) race/ethnicity being the strongest predictors of 25-OHD levels <30 ng/mL.

Conclusions: In these children, 25-OHD was not associated with insulin resistance or cardiovascular risks. Considering age, race/ethnicity, diet, and season may help identify young obese children needing vitamin D management.


Corresponding author: Helen J. Binns, MD, MPH, Pediatrics, Ann & Robert H. Lurie Children’s Hospital of Chicago, 225 East Chicago Avenue, #157, Chicago, IL 60611, USA, Phone: +312-227-7022, Fax: +312-227-9523

Received: 2012-7-27
Accepted: 2012-9-17
Published Online: 2012-10-25
Published in Print: 2013-02-01

©2013 by Walter de Gruyter Berlin Boston

Articles in the same Issue

  1. Masthead
  2. Masthead
  3. Review Article
  4. Clinical and diagnostic characteristics of hyperprolactinemia in childhood and adolescence
  5. Images in Pediatric Endocrinology
  6. Early occurrence of cerebral white matter abnormality detected in a neonate with salt-wasting congenital adrenal hyperplasia
  7. Original Articles
  8. Pentoxifylline treatment for protecting diabetic retinopaty in children with type 1 diabetes
  9. Absence of diabetes mellitus type 2 in obese children and adolescents in the north of Spain
  10. Ceramide mediates inhibition of the Akt/eNOS pathway by high levels of glucose in human vascular endothelial cells
  11. Short- and middle-term continuous use of cinacalcet in children on peritoneal dialysis
  12. Congenital hypothyroidism caused by a novel mutation of the dual oxidase 2 (DUOX2) gene
  13. Arginine-guanidinoacetate-creatine pathway in preterm newborns: creatine biosynthesis in newborns
  14. The effect of different nutritional states on puberty onset and the expression of hypothalamic Kiss1/kisspepetin
  15. Celiac disease and dermatitis herpetiformis in Brazilian twins: a long-term follow-up and screening of their relatives
  16. Glucocorticoid receptor expression in whole blood with preterm infants
  17. Trends in hospitalizations among children with type 1 diabetes in Spain, 2001–2009
  18. Effects of a combined intervention for treating severely obese prepubertal children
  19. Vitamin D levels, insulin resistance, and cardiovascular risks in very young obese children
  20. Prevalence of metabolic syndrome in children and adolescents — the recent trends in South Korea
  21. Elevated visfatin levels in obese children are related to proinflammatory factors
  22. Patient reports
  23. A clinically euthyroid child with a large goiter due to a thyroglobulin gene defect: clinical features and genetic studies
  24. Immune thrombocytopenic purpura in a child with thyroid hormone resistance – a rare presentation
  25. Attempted suicide with levothyroxine in an adolescent girl
  26. Differentiated thyroid carcinoma in a girl with resistance to thyroid hormone management with triiodothyroacetic acid
  27. Brothers with germline PTEN mutations and persistent hypoglycemia, macrocephaly, developmental delay, short stature, and coagulopathy
  28. DEND syndrome due to V59A mutation in KCNJ11 gene: unresponsive to sulfonylureas
  29. Severe short stature due to 3-M syndrome with a novel OBSL1 gene mutation
  30. Mild form of 3-methylglutaconic aciduria type IV and mutation in the TMEM70 genes
  31. Conn syndrome and Crohn disease in a pediatric case: an interesting parallel
  32. Adolescent ischemic stroke associated with anabolic steroid and cannabis abuse
  33. Anorexia nervosa in a patient with congenital adrenal hyperplasia
  34. Severe hypothalamopituitary dysfunction accompanied by influenza-associated encephalopathy: report of two pediatric cases
  35. Octreotide-induced hepatitis in a child with persistent hyperinsulinemia hypoglycemia of infancy
  36. Hepatitis in an infant treated with octreotide for congenital hyperinsulinism
  37. Letters to the Editor
  38. Delayed cord clamping in full-term neonates: is it time for outlining exclusion criteria?
  39. And what about cord blood cardiac troponin I (cTnI) levels as an inclusion criterion for therapeutic hypothermia after perinatal asphyxia?
  40. Duplication of SOX9 is not a common cause of 46,XX testicular or 46,XX ovotesticular DSD
  41. Association of the interferon-γ (IFN-γ) gene polymorphism with endometriosis: is epidermal growth factor (EGF) the key-mediator?
Downloaded on 18.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/jpem-2012-0244/html
Scroll to top button